PRES Following Administration of DHE in a Patient With Unsuspected Pheochromocytoma

We describe neurological complications which manifested after a patient with unsuspected pheochromocytoma was administered dihydroergotamine. Following administration of dihydroergotamine, the patient developed Balint syndrome, with the appearance of symmetric, bilateral occipital signal change on m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Headache 2008-09, Vol.48 (8), p.1237-1239
Hauptverfasser: Kelley, Brendan J., Samples, Stephen, Kunkel, Robert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1239
container_issue 8
container_start_page 1237
container_title Headache
container_volume 48
creator Kelley, Brendan J.
Samples, Stephen
Kunkel, Robert
description We describe neurological complications which manifested after a patient with unsuspected pheochromocytoma was administered dihydroergotamine. Following administration of dihydroergotamine, the patient developed Balint syndrome, with the appearance of symmetric, bilateral occipital signal change on magnetic resonance imaging suggestive of posterior reversible encephalopathy syndrome.
doi_str_mv 10.1111/j.1526-4610.2008.01154.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20974916</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20974916</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5004-58a3b3fcf951a294f71853bd426cfda1db7c9fffa103f15dc2005b949a35ae963</originalsourceid><addsrcrecordid>eNqNkV-PEyEUxYnRuHX1KxheNL5MhRn-DC8m3W67NWm0cXftI2EYsNSZocI02357GdvUNyMvkMvvnns4AAAxGuO0Pm7HmOYsIywVcoTKMcKYkvHhGRhdLp6DEUKYZyUn5RV4FeMWIUSYYC_BFS4p4TkjI3C_-ja7h3PfNP7JdT_gpG5d52IfVO98B72Ft4sZdB1UcJVKpuvh2vUb-NjFfdwZ3ZsarjbG603wrdfH3rfqNXhhVRPNm_N-DR7ns4fpIlt-vfs8nSwzTZOTjJaqqAqrraBY5YJYnmwVVU1ypm2tcF1xLay1CqPCYlrr9FJaCSJUQZURrLgG70-6u-B_7U3sZeuiNk2jOuP3UeZIcCLwAH74J4gpQ7jAgg9oeUJ18DEGY-UuuFaFo8RIDtnLrRwilkPEcshe_sleHlLr2_OUfdWa-m_jOewEvDsDKmrV2KA67eKFyxGjHDGRuE8n7sk15vjfBuRiNrkdjkkgOwmkjzSHi4AKPyXjBady_eVOTucPa3wz_y6XxW_m8q36</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1560131976</pqid></control><display><type>article</type><title>PRES Following Administration of DHE in a Patient With Unsuspected Pheochromocytoma</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Kelley, Brendan J. ; Samples, Stephen ; Kunkel, Robert</creator><creatorcontrib>Kelley, Brendan J. ; Samples, Stephen ; Kunkel, Robert</creatorcontrib><description>We describe neurological complications which manifested after a patient with unsuspected pheochromocytoma was administered dihydroergotamine. Following administration of dihydroergotamine, the patient developed Balint syndrome, with the appearance of symmetric, bilateral occipital signal change on magnetic resonance imaging suggestive of posterior reversible encephalopathy syndrome.</description><identifier>ISSN: 0017-8748</identifier><identifier>EISSN: 1526-4610</identifier><identifier>DOI: 10.1111/j.1526-4610.2008.01154.x</identifier><identifier>PMID: 18547264</identifier><identifier>CODEN: HEADAE</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adult ; Analgesics, Non-Narcotic - adverse effects ; Balint syndrome ; Biological and medical sciences ; dihydroergotamine ; Dihydroergotamine - adverse effects ; Headache - chemically induced ; Human viral diseases ; Humans ; Hypertensive Encephalopathy - chemically induced ; Infectious diseases ; Male ; Medical sciences ; Neurology ; pheochromocytoma ; Pheochromocytoma - drug therapy ; posterior reversible encephalopathy syndrome ; Seizures - chemically induced ; Vascular diseases and vascular malformations of the nervous system ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Vision Disorders - chemically induced</subject><ispartof>Headache, 2008-09, Vol.48 (8), p.1237-1239</ispartof><rights>2008 the Authors. Journal compilation © 2008 American Headache Society</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5004-58a3b3fcf951a294f71853bd426cfda1db7c9fffa103f15dc2005b949a35ae963</citedby><cites>FETCH-LOGICAL-c5004-58a3b3fcf951a294f71853bd426cfda1db7c9fffa103f15dc2005b949a35ae963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1526-4610.2008.01154.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1526-4610.2008.01154.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20657069$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18547264$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kelley, Brendan J.</creatorcontrib><creatorcontrib>Samples, Stephen</creatorcontrib><creatorcontrib>Kunkel, Robert</creatorcontrib><title>PRES Following Administration of DHE in a Patient With Unsuspected Pheochromocytoma</title><title>Headache</title><addtitle>Headache</addtitle><description>We describe neurological complications which manifested after a patient with unsuspected pheochromocytoma was administered dihydroergotamine. Following administration of dihydroergotamine, the patient developed Balint syndrome, with the appearance of symmetric, bilateral occipital signal change on magnetic resonance imaging suggestive of posterior reversible encephalopathy syndrome.</description><subject>Adult</subject><subject>Analgesics, Non-Narcotic - adverse effects</subject><subject>Balint syndrome</subject><subject>Biological and medical sciences</subject><subject>dihydroergotamine</subject><subject>Dihydroergotamine - adverse effects</subject><subject>Headache - chemically induced</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Hypertensive Encephalopathy - chemically induced</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>pheochromocytoma</subject><subject>Pheochromocytoma - drug therapy</subject><subject>posterior reversible encephalopathy syndrome</subject><subject>Seizures - chemically induced</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Vision Disorders - chemically induced</subject><issn>0017-8748</issn><issn>1526-4610</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkV-PEyEUxYnRuHX1KxheNL5MhRn-DC8m3W67NWm0cXftI2EYsNSZocI02357GdvUNyMvkMvvnns4AAAxGuO0Pm7HmOYsIywVcoTKMcKYkvHhGRhdLp6DEUKYZyUn5RV4FeMWIUSYYC_BFS4p4TkjI3C_-ja7h3PfNP7JdT_gpG5d52IfVO98B72Ft4sZdB1UcJVKpuvh2vUb-NjFfdwZ3ZsarjbG603wrdfH3rfqNXhhVRPNm_N-DR7ns4fpIlt-vfs8nSwzTZOTjJaqqAqrraBY5YJYnmwVVU1ypm2tcF1xLay1CqPCYlrr9FJaCSJUQZURrLgG70-6u-B_7U3sZeuiNk2jOuP3UeZIcCLwAH74J4gpQ7jAgg9oeUJ18DEGY-UuuFaFo8RIDtnLrRwilkPEcshe_sleHlLr2_OUfdWa-m_jOewEvDsDKmrV2KA67eKFyxGjHDGRuE8n7sk15vjfBuRiNrkdjkkgOwmkjzSHi4AKPyXjBady_eVOTucPa3wz_y6XxW_m8q36</recordid><startdate>200809</startdate><enddate>200809</enddate><creator>Kelley, Brendan J.</creator><creator>Samples, Stephen</creator><creator>Kunkel, Robert</creator><general>Blackwell Publishing Inc</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>200809</creationdate><title>PRES Following Administration of DHE in a Patient With Unsuspected Pheochromocytoma</title><author>Kelley, Brendan J. ; Samples, Stephen ; Kunkel, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5004-58a3b3fcf951a294f71853bd426cfda1db7c9fffa103f15dc2005b949a35ae963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Analgesics, Non-Narcotic - adverse effects</topic><topic>Balint syndrome</topic><topic>Biological and medical sciences</topic><topic>dihydroergotamine</topic><topic>Dihydroergotamine - adverse effects</topic><topic>Headache - chemically induced</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Hypertensive Encephalopathy - chemically induced</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>pheochromocytoma</topic><topic>Pheochromocytoma - drug therapy</topic><topic>posterior reversible encephalopathy syndrome</topic><topic>Seizures - chemically induced</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Vision Disorders - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kelley, Brendan J.</creatorcontrib><creatorcontrib>Samples, Stephen</creatorcontrib><creatorcontrib>Kunkel, Robert</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Headache</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kelley, Brendan J.</au><au>Samples, Stephen</au><au>Kunkel, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PRES Following Administration of DHE in a Patient With Unsuspected Pheochromocytoma</atitle><jtitle>Headache</jtitle><addtitle>Headache</addtitle><date>2008-09</date><risdate>2008</risdate><volume>48</volume><issue>8</issue><spage>1237</spage><epage>1239</epage><pages>1237-1239</pages><issn>0017-8748</issn><eissn>1526-4610</eissn><coden>HEADAE</coden><abstract>We describe neurological complications which manifested after a patient with unsuspected pheochromocytoma was administered dihydroergotamine. Following administration of dihydroergotamine, the patient developed Balint syndrome, with the appearance of symmetric, bilateral occipital signal change on magnetic resonance imaging suggestive of posterior reversible encephalopathy syndrome.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>18547264</pmid><doi>10.1111/j.1526-4610.2008.01154.x</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0017-8748
ispartof Headache, 2008-09, Vol.48 (8), p.1237-1239
issn 0017-8748
1526-4610
language eng
recordid cdi_proquest_miscellaneous_20974916
source MEDLINE; Access via Wiley Online Library
subjects Adult
Analgesics, Non-Narcotic - adverse effects
Balint syndrome
Biological and medical sciences
dihydroergotamine
Dihydroergotamine - adverse effects
Headache - chemically induced
Human viral diseases
Humans
Hypertensive Encephalopathy - chemically induced
Infectious diseases
Male
Medical sciences
Neurology
pheochromocytoma
Pheochromocytoma - drug therapy
posterior reversible encephalopathy syndrome
Seizures - chemically induced
Vascular diseases and vascular malformations of the nervous system
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Vision Disorders - chemically induced
title PRES Following Administration of DHE in a Patient With Unsuspected Pheochromocytoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T04%3A32%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PRES%20Following%20Administration%20of%20DHE%20in%20a%20Patient%20With%20Unsuspected%20Pheochromocytoma&rft.jtitle=Headache&rft.au=Kelley,%20Brendan%20J.&rft.date=2008-09&rft.volume=48&rft.issue=8&rft.spage=1237&rft.epage=1239&rft.pages=1237-1239&rft.issn=0017-8748&rft.eissn=1526-4610&rft.coden=HEADAE&rft_id=info:doi/10.1111/j.1526-4610.2008.01154.x&rft_dat=%3Cproquest_cross%3E20974916%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1560131976&rft_id=info:pmid/18547264&rfr_iscdi=true